Skip to content
The landscape of cancer treatment and market dynamics continues to evolve, shaped by ongoing research, technological advancements, and changing demographics. While common cancers like breast and lung cancer often dominate the headlines, there is a significant, albeit less publicized, spectrum of niche cancer markets, including thyroid cancer, paranasal sinus cancer, castration-resistant prostate cancer, and vulvar […]